Skip to content
Trial Eligibility
Menu

Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy

NCT07122739

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study tests the efficacy of a new behavioral intervention with the goal of reducing spontaneous recovery of threat expectancy in healthy adults. This real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention delivers feedback based on a functional connection between the prefrontal cortex and the hippocampus.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Healthy

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 50 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Trustees of Princeton University
Last updated on ClinicalTrials.gov
February 23, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 1

  • Princeton Neuroscience Institute · Princeton, NJ

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.